C. Delpierre, R. Dray-spira, L. Cuzin, B. Marchou, P. Massip et al., Correlates of late HIV diagnosis: implications for testing policy, International Journal of STD & AIDS, vol.18, issue.5, pp.312-317, 2007.
DOI : 10.1258/095646207780749709
URL : https://hal.archives-ouvertes.fr/inserm-00149998

C. Delpierre, L. Cuzin, V. Lauwers-cances, B. Marchou, and T. Lang, High-Risk Groups for Late Diagnosis of HIV Infection: A Need for Rethinking Testing Policy in the General Population, AIDS Patient Care and STDs, vol.20, issue.12, pp.238-285, 2006.
DOI : 10.1089/apc.2006.20.838

C. Sabin, C. Smith, M. Youle, F. Lampe, D. Bell et al., Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers, AIDS, vol.20, issue.1, pp.67-71, 2005.
DOI : 10.1097/01.aids.0000196178.73174.24

T. Chadborn, K. Baster, V. Delpech, C. Sabin, K. Sinka et al., No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993???2002), AIDS, vol.19, issue.5, pp.513-533, 1993.
DOI : 10.1097/01.aids.0000162340.43310.08

R. Yeni, Prise en charge thérapeutique des personnes infectées par le VIH, 2006.

C. Lewden, E. Jougla, A. Alioum, G. Pavillon, L. Lievre et al., Number of deaths among HIV-infected adults in France in 2000, three-source capture???recapture estimation, Epidemiology and Infection, vol.134, issue.06, pp.1-8, 2006.
DOI : 10.1017/S095026880600639X

M. Kamb, M. Fishbein, J. Douglas, . Jr, F. Rhodes et al., Efficacy of Risk-Reduction Counseling to Prevent Human Immunodeficiency Virus and Sexually Transmitted Diseases, JAMA, vol.280, issue.13, pp.1161-1168, 1998.
DOI : 10.1001/jama.280.13.1161

T. Quinn, M. Wawer, N. Sewankambo, D. Serwadda, C. Li et al., Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1, New England Journal of Medicine, vol.342, issue.13, pp.921-929, 2000.
DOI : 10.1056/NEJM200003303421303

J. Cook, E. Dasbach, P. Coplan, L. Markson, D. Yin et al., Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial, AIDS Research and Human Retroviruses, vol.15, issue.6, pp.499-508, 1999.
DOI : 10.1089/088922299311024

J. Mellors, A. Munoz, J. Giorgi, J. Margolick, C. Tassoni et al., Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection, Annals of Internal Medicine, vol.126, issue.12, pp.946-54, 1997.
DOI : 10.7326/0003-4819-126-12-199706150-00003

D. Vincenzi and I. , A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners, New England Journal of Medicine, vol.331, issue.6, pp.341-347, 1994.
DOI : 10.1056/NEJM199408113310601

H. Krentz, M. Auld, and M. Gill, The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection, HIV Medicine, vol.89, issue.2, pp.93-101, 2004.
DOI : 10.1001/archinte.159.7.758

Y. Yazdanpanah, S. Goldie, E. Losina, M. Weinstein, J. Lebrun et al., Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy, Antivir Ther, vol.7, pp.257-66, 2002.

A. Paltiel, M. Weinstein, A. Kimmel, G. Seage, E. Losina et al., Expanded Screening for HIV in the United States ??? An Analysis of Cost-Effectiveness, New England Journal of Medicine, vol.352, issue.6, pp.586-95, 2005.
DOI : 10.1056/NEJMsa042088

. Sidaction, Le sida en France. www.sidaction.org/informer/sidafrance

G. Marks, N. Crepaz, and R. Janssen, Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA, AIDS, vol.20, issue.10, pp.1447-50, 2006.
DOI : 10.1097/01.aids.0000233579.79714.8d